Results 21 to 30 of about 23,943 (202)

Dipyridamole

open access: yesReactions Weekly
Ali Hassan R, Patel P.
europepmc   +2 more sources

Spectroscopic and Fluorometric Determination of Cinnarizine and Dipyridamole in Pharmaceutical Tablets Using Eosin Y Dye [PDF]

open access: yesمجلة التربية والعلم, 2013
Spectrophotometric and spectrofluorimetric methods were developed for the determination of cinnarizine and dipyridamole. The spectrophotometric method is based on the formation of ion pair complex  between the studied drugs and eosin Y which shows ...
Zeina Al - Abdali, Elham Saleh
doaj   +1 more source

Dipyridamole plus aspirin versus aspirin alone in the secondary prevention after TIA or stroke: a meta-analysis by risk [PDF]

open access: yes, 2008
Objectives: Our aim was to study the effect of combination therapy with aspirin and dipyridamole (A+D) over aspirin alone (ASA) in secondary prevention after transient ischemic attack or minor stroke of presumed arterial origin and to perform subgroup ...
A Algra   +6 more
core   +2 more sources

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study

open access: yesFrontiers in Neurology, 2018
Background and Purpose: No previous study has compared the impact of dipyridamole-based triple antiplatelet therapy on secondary stroke prevention and long-term outcomes to that of dual antiplatelet therapy (DAPT) in patients with acute myocardial ...
Mei-Tzu Wang   +20 more
doaj   +1 more source

The association of rate pressure product (RPP) and myocardial perfusion imaging (MPI) findings: A preliminary study [PDF]

open access: yes, 2012
Introduction: The product of heart rate and systolic blood pressure, termed as rate-pressure product (RPP), is a very reliable indicator of myocardial oxygen demand and is widely used clinically.
Abbaszadeh, M.   +11 more
core   +1 more source

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors

open access: yesFrontiers in Cardiovascular Medicine, 2022
IntroductionCardiovascular events are common in COVID-19. While the use of anticoagulation during hospitalization has been established in current guidelines, recommendations regarding antithrombotic therapy in the post-discharge period are conflicting ...
Lukas J. Motloch   +18 more
doaj   +1 more source

Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke:Pooled analysis of randomized trials [PDF]

open access: yes, 2015
Background and Purpose: Lacunar stroke accounts for ≈25% of ischemic stroke, but optimal antiplatelet regimen to prevent stroke recurrence remains unclear.
Benavente, Oscar R.   +5 more
core   +1 more source

Dipyridamole treatment is associated with improved renal outcome and patient survival in advanced chronic kidney disease

open access: yesKaohsiung Journal of Medical Sciences, 2014
Dipyridamole has been shown to decrease proteinuria and improve renal function progression especially in early chronic kidney disease (CKD) patients with glomerulonephropathy.
Chi-Chih Hung   +8 more
doaj   +1 more source

Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death

open access: yesMolecular Oncology, 2020
Dipyridamole, an antiplatelet drug, has been shown to synergize with statins to induce cancer cell‐specific apoptosis. However, given the polypharmacology of dipyridamole, the mechanism by which it potentiates statin‐induced apoptosis remains unclear ...
Joseph Longo   +5 more
doaj   +1 more source

Multifunctional star-shaped polylactic acid implants for use in angioplasty [PDF]

open access: yes, 2014
Star-shaped polylactic acids with different tacticity were synthesized and both polymers are capable of bestowing properties of anticoagulation and angiogenesis to their living host.
Kiran, M. S.   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy